News

Recent News

01/14/2025

CvilleBioHub Enters Into A Virginia Collaboration Network And Will Launch New Biotech Accelerator In Charlottesville

The biotechnology and innovation landscape in Virginia is set for significant growth, thanks to a recent award from the state’s GO Virginia economic development program and a strategic partnership between CvilleBioHub and the University of Virginia (UVA).This award will inject a crucial business component into Virginia’s existing biotech ecosystem, bolstering the success of high-potential, early-stage life

01/13/2025

Biotech Executive & Venture Fund Founder Lisa Bowers Named Managing Director of UVA’s New Enterprise Studio

The University of Virginia Licensing & Ventures Group has named accomplished entrepreneur, board member and executive Lisa Bowers managing director of its new Enterprise Studio, a facility in downtown Charlottesville designed specifically for faculty and graduate students who would like help commercializing their research. The Studio is a partnership between UVA LVG and UVA Innovates,

12/19/2024

Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announces FDA clearance to initiate a new additional Netherton Syndrome (NS) clinical study for QRX003. QRX003 is a topical lotion that contains a broad-spectrum serine protease inhibitor designed to target the kallikreins in